Evernorth Announces New Cost and Transparency Protections for its Express Scripts Patients
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Raymond James Reiterates Strong Buy Rating on CIGNA (CI)
January 30, 2025 8:44 AM ESTRaymond James analyst John Ransom reiterated a Strong Buy rating and $415.00 price target on CIGNA (NYSE: CI)
The analyst comments "Event: This morning, Cigna reported 4Q24 results that significantly missed expectations, with adj. revenue of $65.7B (Street: $63.1B; RJ: $64.9B), adj. EBT of $2.23B (Street $2.78B; RJ: $2.84B), and adj. EPS of $6.64 (Street: $7.82; RJ: $7.78), while MLR came in at 87.9% (Street: 84.7%, RJ: 84.9%). At first glance, the main highlight of the... More
BofA on CIGNA (CI): 'Quarter and outlook disappoint, valuation pressured'
January 30, 2025 8:37 AM ESTBofA Securities analyst Adam Ron reiterated a Buy rating and $420.00 price target on CIGNA (NYSE: CI).
The analyst comments "CI unexpectantly missed 4Q earnings by 13% in the quarter ($1.03), and lowered its view of 2025 by $1.74 (6%). With the new outlook, the company is now... More
